The risk or severity of adverse effects can be increased when Ramipril is combined with Propacetamol. Aliskiren may increase the hyperkalemic activities of Ramipril. The serum concentration of Estrogens, esterified can be decreased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Indobufen. The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Pindolol. The risk or severity of adverse effects can be increased when Ramipril is combined with Isoxsuprine. The serum concentration of Theophylline can be decreased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Torasemide. The risk or severity of adverse effects can be increased when Ramipril is combined with Olsalazine. The serum concentration of Ramipril can be decreased when it is combined with Garlic. The risk or severity of adverse effects can be increased when Ramipril is combined with Dinutuximab. Ramipril may increase the hypotensive activities of Lofexidine. The serum concentration of Esmirtazapine can be increased when it is combined with Ramipril. Ramipril may increase the hypotensive activities of Dorzolamide. The risk or severity of adverse effects can be increased when Ramipril is combined with Naproxen. Mebanazine may increase the hypotensive activities of Ramipril. Ramipril may increase the hypotensive activities of Remikiren. Toloxatone may increase the hypotensive activities of Ramipril. Ramipril may increase the hypotensive activities of Naftopidil. The risk or severity of adverse effects can be increased when Ramipril is combined with Azelastine. The risk or severity of adverse effects can be increased when Ramipril is combined with Bretylium. The risk or severity of adverse effects can be increased when Morphine is combined with Ramipril. The risk or severity of adverse effects can be increased when Saprisartan is combined with Ramipril. The risk or severity of adverse effects can be increased when Remifentanil is combined with Ramipril. Barbital may increase the hypotensive activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Nabumetone. The risk or severity of adverse effects can be increased when Ramipril is combined with Zileuton. The risk or severity of adverse effects can be increased when Ramipril is combined with Bromfenac. The risk or severity of adverse effects can be increased when Ramipril is combined with Terazosin. Quinine may increase the hypotensive activities of Ramipril. The serum concentration of Rosuvastatin can be increased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Adapalene. The risk or severity of adverse effects can be increased when Ramipril is combined with Nimodipine. The risk or severity of adverse effects can be increased when Imidapril is combined with Ramipril. Heparin may increase the hyperkalemic activities of Ramipril. Phenoxypropazine may increase the hypotensive activities of Ramipril. The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Ramipril. Ramipril may increase the hypotensive activities of Unoprostone. The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Ramipril. Urapidil may increase the hypotensive activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Betaxolol. Primidone may increase the hypotensive activities of Ramipril. Iproniazid may increase the hypotensive activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Nisoldipine. The risk or severity of adverse effects can be increased when Ramipril is combined with Carteolol. Moxonidine may increase the hypotensive activities of Ramipril. The serum concentration of Methallenestril can be decreased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Sufentanil is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Reserpine. The serum concentration of Mirtazapine can be increased when it is combined with Ramipril. Debrisoquin may increase the hypotensive activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Indomethacin. The risk or severity of adverse effects can be increased when Ramipril is combined with Seratrodast. The risk or severity of adverse effects can be increased when Pipamperone is combined with Ramipril. Caroxazone may increase the hypotensive activities of Ramipril. Ramipril may increase the hypotensive activities of Sitaxentan. Trimethaphan may increase the hypotensive activities of Ramipril. Tizanidine may increase the hypotensive activities of Ramipril. Furazolidone may increase the hypotensive activities of Ramipril. Ramipril may increase the hypotensive activities of Trichlormethiazide. The risk or severity of adverse effects can be increased when Telmisartan is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Clevidipine. Trimethoprim may increase the hyperkalemic activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Tolfenamic Acid. The risk or severity of adverse effects can be increased when Carbetocin is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Nebivolol. Iloprost may increase the hypotensive activities of Ramipril. Ketanserin may increase the hypotensive activities of Ramipril. Ramipril may increase the hypotensive activities of Manidipine. The serum concentration of Clomipramine can be increased when it is combined with Ramipril. The metabolism of Tacrolimus can be decreased when combined with Ramipril. Indoramin may increase the hypotensive activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Antipyrine. Reviparin may increase the hyperkalemic activities of Ramipril. Ramipril may increase the hypotensive activities of Zofenopril. The risk or severity of adverse effects can be increased when Levosimendan is combined with Ramipril. Ramipril may increase the hypotensive activities of Epoprostenol. The risk or severity of adverse effects can be increased when Ramipril is combined with Masoprocol. The serum concentration of Etravirine can be decreased when it is combined with Ramipril. Octamoxin may increase the hypotensive activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Lisinopril. The risk or severity of adverse effects can be increased when Ramipril is combined with Labetalol. The risk or severity of adverse effects can be increased when Propofol is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Carprofen. Thiopental may increase the hypotensive activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Etoricoxib. The risk or severity of adverse effects can be increased when Ramipril is combined with Indapamide. The risk or severity of adverse effects can be increased when Ramipril is combined with Nepafenac. Selegiline may increase the hypotensive activities of Ramipril. Phenelzine may increase the hypotensive activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Tarenflurbil. The risk or severity of adverse effects can be increased when Ramipril is combined with Propranolol. Ramipril may increase the hypotensive activities of Macitentan. The risk or severity of adverse effects can be increased when Ramipril is combined with Captopril. Carbaspirin calcium may decrease the antihypertensive activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Papaverine. The risk or severity of adverse effects can be increased when Ramipril is combined with Felodipine. The risk or severity of adverse effects can be increased when Rotigotine is combined with Ramipril. Ramipril may increase the hypotensive activities of Ticrynafen. The risk or severity of adverse effects can be increased when Ramipril is combined with Bufexamac. The risk or severity of adverse effects can be increased when Ramipril is combined with Moexipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Resveratrol. The risk or severity of adverse effects can be increased when Ramipril is combined with Salicylamide. The serum concentration of Ergonovine can be increased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Nadolol. The risk or severity of adverse effects can be increased when Ramipril is combined with Bucillamine. The risk or severity of adverse effects can be increased when Ramipril is combined with Furosemide. The serum concentration of Cabergoline can be increased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Isoflurane is combined with Ramipril. The serum concentration of Abacavir can be decreased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Niflumic Acid. The risk or severity of adverse effects can be increased when Ramipril is combined with Zomepirac. The risk or severity of adverse effects can be increased when Forasartan is combined with Ramipril. Brofaromine may increase the hypotensive activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Tinoridine. The risk or severity of adverse effects can be increased when Ramipril is combined with Oxyphenbutazone. Ramipril may increase the hypotensive activities of Obinutuzumab. The risk or severity of adverse effects can be increased when Ramipril is combined with Pimecrolimus. Icatibant may decrease the antihypertensive activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Azapropazone. The serum concentration of Alprazolam can be increased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Perindopril. Pivhydrazine may increase the hypotensive activities of Ramipril. The serum concentration of Riociguat can be increased when it is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Zaltoprofen. Nitroaspirin may decrease the antihypertensive activities of Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Apraclonidine. The risk or severity of adverse effects can be increased when Vildagliptin is combined with Ramipril. The risk or severity of adverse effects can be increased when Ramipril is combined with Ibuproxam.